Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Srilakshmi

Showing results (481-490 of 582) with videos related to

Pageof 59
Sort By:
JCI Insight|April 6, 2018
Peptide vaccine immunotherapy biomarkers and response patterns in pediatric gliomasSören Müller, Sameer Agnihotri, Karsen E Shoger, et al.
Rheumatology (Oxford, England)|March 24, 2022
Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APSHongjiang Liu, Chun Li, Hui Shi, et al.
Archives of Iranian Medicine|March 3, 2009
Antioxidants and lipid peroxidation status in diabetic patients with and without complicationsRama Srivatsan, Sujata Das, Ranjita Gadde, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19Hui Shi, Yu Zuo, Srilakshmi Yalavarthi, et al.
The Journal of Surgical Research|July 16, 2025
Patient Perspectives on Weight Management and Wellness After Liver Transplantation: A Convergent Mixed Methods StudyNatalia Rodriguez-Payan, Srilakshmi Atthota, Maria P Cote, et al.
Cancer Cell|October 3, 2006
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulatorsHaley Hieronymus, Justin Lamb, Kenneth N Ross, et al.
The Lancet. Neurology|November 20, 2021
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trialBenedikt Schoser, Mark Roberts, Barry J Byrne, et al.
Science Translational Medicine|March 29, 2013
NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritisRitika Khandpur, Carmelo Carmona-Rivera, Anuradha Vivekanandan-Giri, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2005
100 or 30 years after Janeway or Bartter, Healthwatch helps avoid 'flying blind'Germaine Cornélissen, Franz Halberg, Earl Bakken, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 2025
Global Longitudinal Strain: A Potential Noninvasive Tool for Early Detection of Radiation-Induced Cardiac Dysfunction in Patients With Lung Cancer Receiving Thoracic Radiation TherapySteven K Montalvo, Brian Lue, Eugenia Kakadiaris, et al.
Pageof 59

Showing results (481-490 of 582) with videos related to

Sort By:
Pageof 59
JCI Insight|April 6, 2018
Peptide vaccine immunotherapy biomarkers and response patterns in pediatric gliomasSören Müller, Sameer Agnihotri, Karsen E Shoger, et al.
Rheumatology (Oxford, England)|March 24, 2022
Soluble LILRA3 is aberrantly expressed in antiphospholipid syndrome (APS) and is a potential marker of thrombotic APSHongjiang Liu, Chun Li, Hui Shi, et al.
Archives of Iranian Medicine|March 3, 2009
Antioxidants and lipid peroxidation status in diabetic patients with and without complicationsRama Srivatsan, Sujata Das, Ranjita Gadde, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Neutrophil calprotectin identifies severe pulmonary disease in COVID-19Hui Shi, Yu Zuo, Srilakshmi Yalavarthi, et al.
The Journal of Surgical Research|July 16, 2025
Patient Perspectives on Weight Management and Wellness After Liver Transplantation: A Convergent Mixed Methods StudyNatalia Rodriguez-Payan, Srilakshmi Atthota, Maria P Cote, et al.
Cancer Cell|October 3, 2006
Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulatorsHaley Hieronymus, Justin Lamb, Kenneth N Ross, et al.
The Lancet. Neurology|November 20, 2021
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trialBenedikt Schoser, Mark Roberts, Barry J Byrne, et al.
Science Translational Medicine|March 29, 2013
NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritisRitika Khandpur, Carmelo Carmona-Rivera, Anuradha Vivekanandan-Giri, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 10, 2005
100 or 30 years after Janeway or Bartter, Healthwatch helps avoid 'flying blind'Germaine Cornélissen, Franz Halberg, Earl Bakken, et al.
International Journal of Radiation Oncology, Biology, Physics|April 2, 2025
Global Longitudinal Strain: A Potential Noninvasive Tool for Early Detection of Radiation-Induced Cardiac Dysfunction in Patients With Lung Cancer Receiving Thoracic Radiation TherapySteven K Montalvo, Brian Lue, Eugenia Kakadiaris, et al.
Pageof 59